Your browser doesn't support javascript.
loading
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.
Lee, Choong-Kun; Rha, Sun Young; Kim, Hyo Song; Jung, Minkyu; Kang, Beodeul; Che, Jingmin; Kwon, Woo Sun; Park, Sejung; Bae, Woo Kyun; Koo, Dong-Hoe; Shin, Su-Jin; Kim, Hyunki; Jeung, Hei-Cheul; Zang, Dae Young; Lee, Sang Kil; Nam, Chung Mo; Chung, Hyun Cheol.
Afiliação
  • Lee CK; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Rha SY; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim HS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Jung M; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Kang B; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Che J; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Kwon WS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Park S; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Bae WK; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.
  • Koo DH; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Shin SJ; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim H; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Jeung HC; Department of Biostatistics and Computing, Yonsei University College of Medicine, Seoul, South Korea.
  • Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Jeollanam-do, South Korea.
  • Lee SK; Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Nam CM; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
  • Chung HC; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
Nat Commun ; 13(1): 6002, 2022 10 12.
Article em En | MEDLINE | ID: mdl-36224176
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Reino Unido